Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UGT1A1 Polymorphism in Patients With Colorectal Cancer Treated With CPT-11 (Irinotecan)

NCT00003843 is registered in ClinicalTrials.gov with California Cancer Consortium as lead sponsor.

NCT NCT00003843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UGT1A1 Polymorphism in Patients With Colorectal Cancer Treated With CPT-11 (Irinotecan)
Lead sponsor
California Cancer Consortium
Phase
Observational
Overall status
Terminated
Start date
October 31, 1998
Completion date
February 28, 2001
Enrollment
28 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer